【発明の名称】プログラムされた細胞死を含む疾患の治療用組成物 - Yeda Research and Development Company Limited

Title:

【発明の名称】プログラムされた細胞死を含む疾患の治療用組成物

Document Type and Number:

Japanese Patent JP2002511739

Kind Code:

A

Abstract:

DNA molecules comprising a nucleic acid sequence expressed in cells, the expression product of which is involved in programmed cell death. Also disclosed are methods of therapeutic treatment using the DNA molecules and their expression products, and pharmaceutical compositions containing them.

More Like This:

WO/2000/063690	ENRICHED ANTIGEN-SPECIFIC T-CELLS, AND RELATED THERAPEUTIC AND PROPHYLACTIC COMPOSITIONS AND METHODS
JPWO2002047474	HLA-A24 expression transgenic animals and their use

Inventors:

Kimchi, Aday

Application Number:

JP53833298A

Publication Date:

April 16, 2002

Filing Date:

March 03, 1998

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Yeda Research and Development Company Limited

International Classes:

G01N33/50; A61K31/7088; A61K48/00; A61P25/16; A61P25/28; A61P35/00; A61P43/00; C07K14/47; C07K16/18; C12N9/12; C12N9/64; C12N15/09; C12N15/113; C12N15/12; C12N15/19; C12Q1/68; G01N33/53; G01N33/566; G01N33/574; (IPC1-7): C12N15/09; A61K31/7088; A61K48/00; A61P25/16; A61P25/28; A61P35/00; A61P43/00; C12Q1/68; G01N33/50; G01N33/53; G01N33/566; G01N33/574

Attorney, Agent or Firm:

Akira Asamura (3 outside)

Previous Patent: ニュールツリン受容体

Next Patent: ＰＳＣＡ：前立腺幹細胞抗原